KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2024)

Historic Accumulated Expenses for Elanco Animal Health (ELAN) over the last 8 years, with Q4 2024 value amounting to $177.0 million.

  • Elanco Animal Health's Accumulated Expenses rose 1273.89% to $177.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $177.0 million, marking a year-over-year increase of 1273.89%. This contributed to the annual value of $177.0 million for FY2024, which is 1273.89% up from last year.
  • Latest data reveals that Elanco Animal Health reported Accumulated Expenses of $177.0 million as of Q4 2024, which was up 1273.89% from $157.0 million recorded in Q4 2023.
  • Over the past 5 years, Elanco Animal Health's Accumulated Expenses peaked at $185.0 million during Q4 2021, and registered a low of $56.2 million during Q1 2020.
  • For the 5-year period, Elanco Animal Health's Accumulated Expenses averaged around $128.6 million, with its median value being $136.0 million (2022).
  • As far as peak fluctuations go, Elanco Animal Health's Accumulated Expenses soared by 11678.32% in 2021, and later plummeted by 2108.11% in 2022.
  • Quarter analysis of 5 years shows Elanco Animal Health's Accumulated Expenses stood at $144.0 million in 2020, then increased by 28.47% to $185.0 million in 2021, then dropped by 21.08% to $146.0 million in 2022, then grew by 7.53% to $157.0 million in 2023, then increased by 12.74% to $177.0 million in 2024.
  • Its last three reported values are $177.0 million in Q4 2024, $157.0 million for Q4 2023, and $110.0 million during Q1 2023.